Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung can (Q46093018)
Jump to navigation
Jump to search
scientific article published on 10 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung can |
scientific article published on 10 March 2009 |
Statements
1 reference
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung can (English)
1 reference
1 reference
T Grodzki
1 reference
E H Tan
1 reference
J Rolski
1 reference
C P Schneider
1 reference
U Gatzemeier
1 reference
P Zatloukal
1 reference
E Aitini
1 reference
H Riska
1 reference
Y H Tsai
1 reference
R Abratt
1 reference
10 March 2009
1 reference
1 reference
20
1 reference
7
1 reference
1249-1256
1 reference
Identifiers
1 reference
1 reference